| L-arginine role for stone lower ureter: A randomized controlled trial 2025 · L-Arginine group · Adults older than 18 with a single distal ureteral stone measuring 4–10 mm | 1 g | 4 weeks | 51 |
| Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis--a randomised trial 2011 · Arginine-rich food supplement (peanuts) · Smear-positive tuberculosis patients; age and sex not reported | 1 g | 4 weeks | — |
| Beneficial effect of l-arginine in women using assisted reproductive technologies: a small-scale randomized controlled trial 2020 · AS1000 group · Women aged under 40 undergoing assisted reproductive technology treatment and planning egg retrieval for embryo transfer | 1 g | 90 days | 37 |
| Ultrasound evaluation of intrauterine growth restriction therapy by a nitric oxide donor (L-arginine) 2004 · L-arginine-treated group · Pregnant women with ultrasound-diagnosed intrauterine growth restriction | 3 g | 20 days | 78 |
| Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study) 2018 · L-arginine group · Middle-aged men and women with impaired glucose tolerance and metabolic syndrome | 6.4 g | 540 days | 72 |
| Effect of three different doses of arginine enhanced enteral nutrition on nutritional status and outcomes in well nourished postsurgical cancer patients: a randomized single blinded prospective trial 2015 · Group I · Adults with oral or laryngeal cancer undergoing surgery | 5.7 g | — | 28 |
| Effect of three different doses of arginine enhanced enteral nutrition on nutritional status and outcomes in well nourished postsurgical cancer patients: a randomized single blinded prospective trial 2015 · Group II · Adults with oral or laryngeal cancer undergoing surgery | 12.3 g | — | 28 |
| Effect of three different doses of arginine enhanced enteral nutrition on nutritional status and outcomes in well nourished postsurgical cancer patients: a randomized single blinded prospective trial 2015 · Group III · Adults with oral or laryngeal cancer undergoing surgery | 18.9 g | — | 28 |
| Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trial 2012 · l-arg · Individuals with impaired glucose tolerance and metabolic syndrome; age and sex not specified | 6.4 g | 548 days | — |
| l-Arginine supplementation in severe asthma 2020 · l-arginine · People with severe asthma | 0.1 mg/kg | — | — |
| Comparative effectiveness of preemptive administration of ibuprofen and ibuprofen-arginine on the anesthetic success of inferior alveolar nerve block in teeth with symptomatic irreversible pulpitis - A double-blind randomized clinical trial 2024 · ibuprofen-arginine · Patients with symptomatic irreversible pulpitis; age and sex not reported | 1.16 g | 1 day | 50 |
| A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis 1999 · L-arginine group · Patients with interstitial cystitis | 1.5 g | 90 days | 27 |
| Effect of l-arginine compared to placebo on sexual function in women with major depressive disorder: a randomized controlled trial 2024 · L-arginine group · Women aged 18–60 with major depressive disorder receiving standard antidepressant treatment | 2 g | 4 weeks | 16 |
| The effect of l-arginine supplementation on body composition and performance in male athletes: a double-blinded randomized clinical trial 2017 · l-arginine group · Male soccer players aged 16–35 years | 2 g | 45 days | — |
| Asymmetric dimethylarginine predicts perioperative cardiovascular complications in patients undergoing medium-to-high risk non-cardiac surgery 2020 · L-arginine/L-citrulline group · Adults aged 30–75 years with ASA score II–IV scheduled for medium-to-high-risk non-cardiac surgery | 666 mg | 5 days | 142 |
| Effect of oral nutritional supplementation on wound healing in diabetic foot ulcers: a prospective randomized controlled trial 2014 · Arginine, glutamine and β-hydroxy-β-methylbutyrate supplementation · Adults aged 28–86 with type 1 or type 2 diabetes and at least one non-infected University of Texas grade 1A diabetic foot ulcer | 14 g | 16 weeks | 129 |
| Beneficial effect of l-arginine in women using assisted reproductive technologies: a small-scale randomized controlled trial 2020 · AS2000 group · Women aged under 40 undergoing assisted reproductive technology treatment and planning egg retrieval for embryo transfer | 2 g | 90 days | 36 |
| Effect of Preoperative Administration of Oral Arginine and Glutamine in Patients with Enterocutaneous Fistula Submitted to Definitive Surgery: a Prospective Randomized Trial 2020 · experimental group · Patients with enterocutaneous fistula undergoing definitive surgery | 4.5 g | 7 days | 20 |
| Perioperative immunonutrition and outcomes in head and neck cancer surgery - a randomized clinical trial: Effects of perioperative immunonutrition in patients with head and neck cancer 2026 · IN (intervention group) · Adults aged 18–75 with newly diagnosed head and neck cancer undergoing first-line surgery; predominantly men; body-weight loss was common | 11.4 g | 15 days | 17 |
| L-arginine supplementation in patients with gestational hypertension: a pilot study 2007 · L-Arg group · Pregnant patients with gestational hypertension, with or without proteinuria | 4 g | 19 days | — |
| Does a pretreatment with a dentine hypersensitivity mouth-rinse compensate the pain caused by professional mechanical plaque removal? A single-blind randomized controlled clinical trial 2021 · ARGI (test 2) · Adults attending periodontal maintenance or dental prophylaxis for primary or secondary periodontal prevention, with gingivitis or periodontitis | 20 mL | 7 days | 52 |
| Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial 2022 · L-arginine group · Men aged 20–73 with vasculogenic erectile dysfunction, including mild-to-moderate erectile dysfunction by IIEF-6 and mild-to-severe vasculogenic dysfunction by dynamic penile Doppler ultrasound | 6 g | 90 days | 51 |
| Adjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow-up 2022 · Group A (treatment group) · Adult men with mild or moderate erectile dysfunction | 2.5 g | 26 weeks | 50 |
| Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial 1998 · L-arginine · Patients with breast cancer undergoing neoadjuvant chemotherapy | 30 g | 3 days | 48 |
| Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation 2014 · L-arginine group · Adults aged 30–60 with simple obesity (BMI ≥30 kg/m²), men and women | 27 g | 26 weeks | 44 |
| Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report 2006 · L-arginine · Pregnant women with preeclampsia; age range not reported | 3 g | — | 42 |
| Effects of oral L-arginine on the pulsatility indices of umbilical artery and middle cerebral artery in preterm labor 2008 · L-arginine group · Women with threatened preterm labor | 3 g | — | 37 |
| Randomized control trial of oral arginine therapy for children with sickle cell anemia hospitalized for pain in Nigeria 2021 · L-arginine · Children aged 5–17 years with sickle cell anemia hospitalized with vaso-occlusive pain crisis | 300 mg/kg | — | 35 |
| l-Arginine Supplementation Alleviates Postprandial Endothelial Dysfunction When Baseline Fasting Plasma Arginine Concentration Is Low: A Randomized Controlled Trial in Healthy Overweight Adults with Cardiometabolic Risk Factors 2016 · SR-l-arginine · Healthy overweight adults with the hypertriglyceridemic waist phenotype and cardiometabolic risk factors | 4.5 g | 4 weeks | 33 |
| L-Arginine is a feasible supplement to heal chronic anal fissure via reducing internal anal sphincter pressure: a randomized clinical trial study 2023 · L-Arginine · Adult men and women aged 18–65 with chronic anal fissure | 3 g | 4 weeks | 33 |
| Comparison of the clinical efficacy of daily use of L-arginine, tadalafil and combined L-arginine with tadalafil in the treatment of elderly patients with erectile dysfunction 2020 · L-arginine · men aged 60 years or older with erectile dysfunction | 5 g | 6 weeks | 30 |
| Comparison of the clinical efficacy of daily use of L-arginine, tadalafil and combined L-arginine with tadalafil in the treatment of elderly patients with erectile dysfunction 2020 · combined L-arginine with tadalafil · men aged 60 years or older with erectile dysfunction | 5 g | 6 weeks | 30 |
| Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study 1999 · L-arginine · Men with confirmed organic erectile dysfunction | 5 g | 6 weeks | 29 |
| Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults 1996 · L-arginine · Hypercholesterolemic adults aged 19–40 with known endothelial dysfunction | 21 g | 4 weeks | 27 |
| Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris 2000 · L-arginine · Patients with stable coronary artery disease; age and sex not reported | 6 g | 3 days | 25 |
| [Effect of L-arginine on platelet aggregation, endothelial function adn exercise tolerance in patients with stable angina pectoris] 2000 · Cardiket in combination with L-arginine · Adults with stable angina of effort, functional class I-II | 15 g | 10 days | 22 |
| L-arginine supplementation prolongs exercise capacity in congestive heart failure 2004 · L-arginine · Patients with stable mild to moderate NYHA II-III congestive heart failure; age and sex not reported | 9 g | 7 days | 21 |
| Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 1999 · Methionine-free fruit juice placebo load · Healthy adults aged 25 to 45 years; 10 men and 10 women | 3 g | 1 day | 20 |
| Comparison of Watermelon and Carbohydrate Beverage on Exercise-Induced Alterations in Systemic Inflammation, Immune Dysfunction, and Plasma Antioxidant Capacity 2016 · Watermelon (WM) condition · 20 male trained cyclists with competitive road-racing and time-trial experience | 465 mg | 2 weeks | 20 |
| A combination of oral L-citrulline and L-arginine improved 10-min full-power cycling test performance in male collegiate soccer players: a randomized crossover trial 2019 · Cit + Arg · Male collegiate soccer players aged 18–25 years | 1.2 g | 7 days | 20 |
| The efficacy of oral L-arginine therapy for the treatment of vaso-occlusive pain episodes in children with sickle cell disease 2025 · Group 1 · Children with sickle cell disease presenting with vaso-occlusive episodes; mean age 8.8 years | 300 mg/kg | 5 days | 20 |
| Transient improvement of acetylcholine responses after short-term oral L-arginine in forearms of human heart failure 2000 · L-arginine · Patients with heart failure; age and sex not reported | 20 g | 1 day | 18 |
| Oral L-arginine improves hemodynamic responses to stress and reduces plasma homocysteine in hypercholesterolemic men 2005 · L-arginine · Middle-aged men with hypercholesterolemia | 12 g | 3 weeks | 16 |
| Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine 2007 · L-arginine alone, high-ADMA group · Clinically asymptomatic elderly subjects in the highest quartile of plasma ADMA (high ADMA) | 3 g | 3 weeks | 15 |
| Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine 2007 · Simvastatin plus L-arginine, high-ADMA group · Clinically asymptomatic elderly subjects in the highest quartile of plasma ADMA (high ADMA) | 3 g | 3 weeks | 15 |
| The effect of L-arginine administration on muscle force and power in postmenopausal women 2008 · L-arginine group · Postmenopausal women, mean age 54.5 years | 18 g | 26 weeks | 15 |
| Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure 1996 · L-arginine hydrochloride · Patients with moderate to severe heart failure; age and sex not specified | 5.6 g | 6 weeks | 15 |
| Effects of arginine-based supplements on the physical working capacity at the fatigue threshold 2010 · 1.5 g arginine group · College-aged men, mean age 23.9 years; untrained individuals | 1.5 g | 4 weeks | 14 |
| Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine 2007 · L-arginine alone, low-ADMA group · Clinically asymptomatic elderly subjects in the lowest quartile of plasma ADMA (low ADMA) | 3 g | 3 weeks | 13 |
| Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine 2007 · Simvastatin plus L-arginine, low-ADMA group · Clinically asymptomatic elderly subjects in the lowest quartile of plasma ADMA (low ADMA) | 3 g | 3 weeks | 13 |
| Oral L-arginine improves endothelial function in healthy individuals older than 70 years 2003 · L-arginine · Healthy adults aged 73.8 ± 2.7 years | 16 g | 2 weeks | 12 |
| The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance 2009 · L-arginine · Healthy young smokers; age and sex not specified | 21 g | 3 days | 12 |
| Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men 1995 · L-arginine · Healthy men aged 27–37 years | 21 g | 3 days | 12 |
| Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals 2008 · L-arginine · Healthy smokers, mean age 24.3 years | 7 g | 3 days | 10 |
| No effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletes 2009 · ARG trial · Well-trained male college judo athletes; age not reported | 6 g | 3 days | 10 |
| Effects of L-arginine supplementation on blood flow, oxidative stress status and exercise responses in young adults with uncomplicated type I diabetes 2013 · L-arginine supplementation · Young adult males with uncomplicated type 1 diabetes | 7 g | 7 days | 10 |
| Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease 1997 · L-arginine · Men aged 41 ± 2 years with angiographically proven coronary atherosclerosis | 21 g | 3 days | 10 |
| Effects of long-term oral L-arginine on esophageal motility and gallbladder dynamics in healthy humans 1998 · L-arginine · Healthy male volunteers | 30 g | 8 days | 10 |
| Effects of Chronic Supplementation of L-Arginine on Physical Fitness in Water Polo Players 2021 · L-Arginine · Male professional water polo players competing in the top-level division of the Italian Championship | 5 g | 4 weeks | 9 |
| Dietary arginine supplementation speeds pulmonary VO2 kinetics during cycle exercise 2009 · L-arginine hydrochloride capsules · Physically active males; age and health condition not specified | 7.2 g | 2 weeks | 7 |
| Syndrome X and endothelial dysfunction 1998 · L-arginine · Patients with Syndrome X (angina, normal coronary arteriogram and positive exercise test), with thallium-201 defects and no known cause of endothelial dysfunction | 14 g | 4 weeks | 7 |
| The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy 2002 · L-arginine · Patients with stable angina pectoris | 2.8 g | 10 days | — |
| No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia 2003 · HeartBar group · Subjects with hypercholesterolemia; age and sex not specified | 6.6 g | 2 weeks | — |
| L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease 2005 · oral L-arginine · Adults with stable coronary artery disease | 10 g | 4 weeks | — |
| Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients 2006 · L-arginine group · Adults with obesity, insulin-resistant type 2 diabetes | 8.3 g | 3 weeks | — |
| Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial 2008 · L-arginine plus VEGF-165 plasmid DNA · Patients with surgical triple-vessel coronary disease and a severely diffusely diseased left anterior descending artery | 6 g | 90 days | — |
| VO2max and ventilatory threshold of trained cyclists are not affected by 28-day L-arginine supplementation 2011 · L-arginine (ARG) · Endurance-trained male cyclists; mean age 36.3 years; no diagnosed condition stated | 12 g | 4 weeks | — |
| The effect of different doses of an arginine-containing supplement on the healing of pressure ulcers 2012 · 4.5 g arginine group · Inpatients with category II, III or IV pressure ulcers | 4.5 g | 3 weeks | — |
| The effect of different doses of an arginine-containing supplement on the healing of pressure ulcers 2012 · 9 g arginine group · Inpatients with category II, III or IV pressure ulcers | 9 g | 3 weeks | — |
| Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial 2012 · L-arginine and HDEL · Premenopausal women with central obesity | 5 g | 6 weeks | — |
| Daily 100% watermelon juice consumption and vascular function among postmenopausal women: A randomized controlled trial 2021 · 100% watermelon juice · Postmenopausal women aged 55–70 years with BMI <30 kg/m² and no stated cardiovascular disease | 1.15 g | 4 weeks | — |
| Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans 1997 · L-arginine hydrochloride · Hypercholesterolemic patients | 8.4 g | 2 weeks | — |
| Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris 1997 · L-arginine · Patients with stable angina pectoris and healed myocardial infarction | 6 g | 3 days | — |
| Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans 1998 · L-arginine · Adults with nonobstructive coronary artery disease and coronary endothelial dysfunction | 9 g | 26 weeks | — |
| Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis 2013 · AGE-S · Subjects evaluated for coronary artery calcium; age, sex, and specific condition are not stated | 100 mg | 1 year | — |
| Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA study) 2025 · L-arginine group · Patients with stable COPD; age and sex not specified | 3.32 g | 4 weeks | 76 |
| A Prospective Study Evaluating the Effects of a Nutritional Supplement Intervention on Cognition, Mood States, and Mental Performance in Video Gamers 2019 · study supplement (nooLVL) · Healthy, non-smoking video gamers aged 18–40 years who played video games at least 5 hours per week | 1.5 g | 7 days | 30 |
| Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women 2004 · experimental treatment group · Elderly women, mean age 76.7 years | 5 g | 12 weeks | 27 |
| Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial 2022 · l-arginine plus vitamin C · Men and women aged 20–60 with long COVID and persistent fatigue | 3.32 g | 4 weeks | 25 |
| L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial 2025 · Group I (L-arginine + maltodextrin oral suspension) · Adults aged 20–70, male and female, with head and neck cancer and radiation-induced oral mucositis, undergoing radiotherapy | 15 g | 5 weeks | 23 |
| Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study 2000 · HMB/Arg/Gln · HIV-infected adults with AIDS-associated wasting and at least 5% documented weight loss in the previous 3 months | 14 g | 8 weeks | 22 |
| Branched-chain amino acids and arginine improve performance in two consecutive days of simulated handball games in male and female athletes: a randomized trial 2015 · AA trial (BCAA + arginine) · Well-trained male and female handball players aged about 20–21 years, competing at national or international level, without known cardiovascular disease risks or musculoskeletal injuries | 40 mg/kg | 2 days | 22 |
| The effects of 4 weeks of an arginine-based supplement on the gas exchange threshold and peak oxygen uptake 2010 · ARGININE group · College-aged males, mean age 22.1 ± 2.4 years, with no stated condition | 3 g | 4 weeks | 21 |
| Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 1999 · Oral methionine load · Healthy adults aged 25 to 45 years; 10 men and 10 women | 3 g | 1 day | 20 |
| Acute effects of an arginine-based supplement on neuromuscular, ventilatory, and metabolic fatigue thresholds during cycle ergometry 2015 · arginine-based supplement condition · Untrained men, mean age 22.0 ± 1.7 years | 3 g | 1 day | 19 |
| Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine 2002 · HMB/Arg/Gln · Patients with advanced solid tumors and at least 5% weight loss | 14 g | 24 weeks | 18 |
| Endothelial Function is improved by Inducing Microbial Polyamine Production in the Gut: A Randomized Placebo-Controlled Trial 2019 · Bifal + Arg YG · Healthy adults aged 30–65 years, non-smokers with BMI below 30 and selected near BMI 25 as at higher risk of atherosclerosis | 600 mg | 12 weeks | 18 |
| Effects of arginine-based supplements on the physical working capacity at the fatigue threshold 2010 · 3.0 g arginine group · College-aged men, mean age 23.9 years; untrained individuals | 3 g | 4 weeks | 17 |
| Acute effects of combined supplementation of L-arginine and citrulline malate on aerobic, anaerobic, and CrossFit exercise performance 2025 · CrossFit–Cindy supplement condition · Healthy, physically active men in the CrossFit group; mean age 24.8 years | 150 mg/kg | 1 day | 16 |
| Acute effects of combined supplementation of L-arginine and citrulline malate on aerobic, anaerobic, and CrossFit exercise performance 2025 · Wingate Anaerobic Test supplement condition · Healthy, physically active men in the Wingate group; mean age 28.9 years | 150 mg/kg | 1 day | 16 |
| L-arginine enriched biscuits improve endothelial function and glucose metabolism: a pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome 2013 · L-arginine-enriched biscuits (crossover study) · 15 obese subjects with impaired glucose tolerance and metabolic syndrome | 6.6 g | 2 weeks | 15 |
| Acute effects of combined supplementation of L-arginine and citrulline malate on aerobic, anaerobic, and CrossFit exercise performance 2025 · Harvard Step Test supplement condition · Healthy, physically active men in the Harvard Step Test group; mean age 22.2 years | 150 mg/kg | 1 day | 14 |
| Effect of administration of β-hydroxy-β-methyl butyrate-enriched formula after liver transplantation: A pilot randomized controlled trial 2020 · HMB group · Adults who underwent living donor liver transplantation | 14 g | 30 days | 12 |
| Effect of a Food for Special Medical Purposes for Muscle Recovery, Consisting of Arginine, Glutamine and Beta-Hydroxy-Beta-Methylbutyrate on Body Composition and Skin Health in Overweight and Obese Class I Sedentary Postmenopausal Women 2021 · supplement group · Women aged 45–65 who were sedentary, postmenopausal, and overweight or obese class I (BMI 25–35 kg/m²) | 7.4 g | 4 weeks | 10 |
| Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support 1996 · study formula · 10 men with symptomatic HIV infection on stable medication regimens | 7.8 g | 120 days | 10 |
| Meal amino acids with varied levels of arginine do not affect postprandial vascular endothelial function in healthy young men 2007 · Meal B · Healthy young men | 3 g | 1 day | 9 |
| Prevention of perceptual-motor decline by branched-chain amino acids, arginine, citrulline after tennis match 2017 · AA trial · Nine male tennis players | 50 mg/kg | 1 day | 9 |
| Oral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humans 2007 · L-lysine and L-arginine treatment · Healthy Japanese adults; age and sex distribution not stated | 2.64 g | 7 days | — |
| Effects of 6-month supplementation with β-hydroxy-β-methylbutyrate, glutamine and arginine on vascular endothelial function of older adults 2016 · supplement group · Community-dwelling men and women aged 65–87 | 14 g | 24 weeks | — |
| Oral Supplementation with Beta-Hydroxy-Beta-Methylbutyrate, Arginine, and Glutamine Improves Lean Body Mass in Healthy Older Adults 2019 · amino acid supplement group · Community-dwelling, ambulatory men and women aged 65 years and older in generally good health | 14 g | 26 weeks | — |
| A Single Dosage of l-Arginine Oral Supplementation Induced Post-Aerobic Exercise Hypotension in Hypertensive Patients 2023 · l-arginine supplementation arm · Treated hypertensive men and women, mean age 62 ± 10 years | 8 g | 1 day | 10 |
| Effects of watermelon supplementation on aortic blood pressure and wave reflection in individuals with prehypertension: a pilot study 2011 · watermelon supplementation · Adults aged 54 ± 3 years with prehypertension; four men and five women | 1.3 g | 6 weeks | 9 |
| Evaluation of the antihypertensive effect of L-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring 2010 · 2 g three times daily · Patients with primary mild hypertension; age and sex not reported | 6 g | 4 weeks | — |
| Evaluation of the antihypertensive effect of L-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring 2010 · 4 g three times daily · Patients with primary mild hypertension; age and sex not reported | 12 g | 4 weeks | — |
| Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial 2011 · 6 g/24-hour L-arginine group · Healthy people; age and sex not specified | 6 g | 4 weeks | — |
| Supplementation with L-arginine does not influence arterial blood pressure in healthy people: a randomized, double blind, trial 2011 · 12 g/24-hours L-arginine group · Healthy people; age and sex not specified | 12 g | 4 weeks | — |
| Combined effects of aerobic exercise and l-arginine ingestion on blood pressure in normotensive postmenopausal women: A crossover study 2016 · arginine+exercise (A-E) · Normotensive postmenopausal women; mean age 57±6 years | 9 g | 1 day | — |
| Effect of L-arginine intake on exercise-induced hypotension 2018 · EX-LARG · Hypertensive adults; mean age 51.47 years; sex not reported | 7 g | 1 day | — |
| Effect of L-arginine intake on exercise-induced hypotension 2018 · L-ARG · Hypertensive adults; mean age 51.47 years; sex not reported | 7 g | 1 day | — |
| L-arginine supplementation to mitigate cardiovascular effects of walking outside in the context of traffic-related air pollution in participants with elevated blood pressure: A randomized, double-blind, placebo-controlled trial 2021 · intervention group · Adults with elevated blood pressure | 9 g | 2 weeks | — |
| L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation 2018 · Nutritional intervention group · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure | 2.4 g | 26 weeks | 40 |
| L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation 2018 · Placebo group receiving open-label TAP in follow-up · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure | 2.4 g | 13 weeks | 40 |
| Combined Effect of Arginine, Valine, and Serine on Exercise-Induced Fatigue in Healthy Volunteers: A Randomized, Double-Blinded, Placebo-Controlled Crossover Study 2019 · AA granule · Healthy men aged 30–59 years | 3.6 g | 2 weeks | 39 |
| Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males 2017 · PWS · Apparently healthy, resistance-trained males; mean age about 21 years | 2 g | 8 weeks | 27 |
| Effects of ingesting a pre-workout dietary supplement with and without synephrine for 8 weeks on training adaptations in resistance-trained males 2017 · PWS + S · Apparently healthy, resistance-trained males; mean age about 22 years | 2 g | 8 weeks | 26 |
| Effects of an L-arginine-based multi ingredient product on endothelial function in subjects with mild to moderate hypertension and hyperhomocysteinemia - a randomized, double-blind, placebo-controlled, cross-over trial 2017 · AbMIP (vasoLoges® protect) · Men and postmenopausal women aged 40–65 with elevated systolic blood pressure and homocysteine ≥10 μmol/L | 2.4 g | 4 weeks | 25 |
| Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 1999 · Methionine load with antioxidant vitamins · Healthy adults aged 25 to 45 years; 10 men and 10 women | 3 g | 1 day | 20 |
| Effects of intake of a mixture of thiamin, arginine, caffeine, and citric acid on adiposity in healthy subjects with high percent body fat 2003 · TACC-supplemented tea · Healthy subjects with body fat percentage ≥25%; ages and sex not reported | 1.24 g | 12 weeks | 16 |
| Branched-chain amino acids, arginine, citrulline alleviate central fatigue after 3 simulated matches in taekwondo athletes: a randomized controlled trial 2016 · AA trial · Male taekwondo athletes, age 20.0 ± 0.8 years, competing at national or international level | 50 mg/kg | 1 day | 12 |
| Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial 2005 · Standard diet plus two high-protein/energy supplements containing additional arginine, vitamin C and zinc · Inpatients aged 37–92 years with stage 2, 3 or 4 pressure ulcers | 9 g | 3 weeks | — |
| Supplemental Protein and a Multinutrient Beverage Speed Wound Healing after Acute Sleep Restriction in Healthy Adults 2022 · NUT · Generally healthy young adults aged 18–approximately 20 years (18 males and 2 females), after acute sleep restriction | 20 g | 7 days | — |
| The effect of 24-hour sleep deprivation and anaerobic exercise on the expression of BAX, BCL2, BMAL1 and CCAR2 genes in peripheral blood mononuclear cells after L-arginine supplementation 2023 · L-arginine intervention group · Healthy men aged 26–35 years | 1 g | 8 weeks | 10 |
| Application of multivariate longitudinal models in SIRT6, FBS, and BMI analysis of the elderly 2019 · Exercise + supplement (ES) group · Elderly men, mean age 63.09 ± 3.71 years | 1 g | 8 weeks | 8 |
| Application of multivariate longitudinal models in SIRT6, FBS, and BMI analysis of the elderly 2019 · Supplement (S) group · Elderly men, mean age 63.09 ± 3.71 years | 1 g | 8 weeks | 8 |
| Nitric-Oxide-Inducing Factors on Vitamin D Changes in Older People Susceptible to Suffer from Sarcopenia 2022 · L-arginine-supplemented group (ARG) · Men and women aged 60–73 in good health and at risk of sarcopenia, participating in a physical activity program | 2 g | 6 weeks | — |
| Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial 2009 · AGE+S · Intermediate-risk adults, mean age 60 ± 9 years; 79% male | 100 mg | 1 year | — |
| L-Arginine reduces lipid peroxidation in patients with diabetes mellitus 1997 · L-arginine treatment (crossover phase) · Adults with diabetes mellitus | 2 g | 90 days | 30 |
| The acute effects of a low and high dose of oral L-arginine supplementation in young active males at rest 2011 · low-dose L-arginine · Physically active males, mean age 25 ± 5 years | 75 mg/kg | 1 day | 14 |
| The acute effects of a low and high dose of oral L-arginine supplementation in young active males at rest 2011 · high-dose L-arginine · Physically active males, mean age 25 ± 5 years | 150 mg/kg | 1 day | 14 |
| L-arginine plus drospirenone-ethinyl estradiol in the treatment of patients with PCOS: a prospective, placebo controlled, randomised, pilot study 2010 · Group II · Young women with PCOS | 8 g | 26 weeks | 13 |
| Pharmacokinetics of intravenous and oral L-arginine in normal volunteers 1999 · oral L-arginine · healthy volunteers; age and sex not stated | 10 g | 1 day | 10 |
| L-arginine and nitric oxide-related compounds in plasma: comparison of normal and arginine-free diets in a 24-h crossover study 1999 · Diet B · Eight healthy volunteers; age and sex not reported | 3.8 g | 1 day | 8 |
| Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free L-arginine in humans 2015 · L-arginine ingestion, peripheral arterial occlusive disease study · Patients with peripheral arterial occlusive disease; age and sex not stated | 10 g | — | — |
| Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free L-arginine in humans 2015 · L-arginine ingestion, coronary artery disease study · Patients with coronary artery disease; age and sex not stated | 10 g | — | — |
| Safety of dietary supplementation with arginine in adult humans 2018 · 15 g Arg/day · Overweight or obese adults (BMI ≥25 kg/m²), otherwise healthy | 15 g | 90 days | — |
| Safety of dietary supplementation with arginine in adult humans 2018 · 30 g Arg/day · Overweight or obese adults (BMI ≥25 kg/m²), otherwise healthy | 30 g | 90 days | — |
| Effects of acute arginine supplementation on neuroendocrine, metabolic, cardiovascular, and mood outcomes in younger men: A double-blind, placebo-controlled trial 2022 · arginine supplement · Healthy, physically active men aged 18–39 years with normal BMI (18.5–25 kg/m²) | 10 g | 1 day | 30 |
| A Slow- Compared with a Fast-Release Form of Oral Arginine Increases Its Utilization for Nitric Oxide Synthesis in Overweight Adults with Cardiometabolic Risk Factors in a Randomized Controlled Study 2016 · Immediate-release arginine (IR-Arg) · Healthy adults: 12 overweight adults with hypertriglyceridemic waist phenotype and 15 healthy control adults | 4.5 g | 7 days | 27 |
| A Slow- Compared with a Fast-Release Form of Oral Arginine Increases Its Utilization for Nitric Oxide Synthesis in Overweight Adults with Cardiometabolic Risk Factors in a Randomized Controlled Study 2016 · Sustained-release arginine (SR-Arg) · Healthy adults: 12 overweight adults with hypertriglyceridemic waist phenotype and 15 healthy control adults | 4.5 g | 7 days | 27 |
| L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides 2009 · L-arginine group · Adults with hypertriglyceridemia | 3 g | 12 weeks | 22 |
| [Effect of L-arginine on platelet aggregation, endothelial function adn exercise tolerance in patients with stable angina pectoris] 2000 · L-arginine group 2 · Adults with stable angina of effort, functional class I-II | 15 g | 10 days | 20 |
| Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study 2019 · L-arginine · Overweight prediabetic Dutch South Asian and Europid men, age 40–55 years | 9 g | 6 weeks | 20 |
| Randomized Clinical and Biochemical Study Comparing the Effect of L-arginine and Sildenafil in Beta Thalassemia Major Children With High Tricuspid Regurgitant Jet Velocity 2022 · L-arginine group · Children with β-thalassemia major and pulmonary hypertension | 0.1 mg/kg | 60 days | 20 |
| Oral L-arginine improves endothelial dysfunction in patients with essential hypertension 2002 · L-arginine · Patients with essential hypertension; age and sex range not reported | 6 g | 1 day | 18 |
| Effects of oral administration of L-arginine on renal function in patients with heart failure 2000 · L-arginine · Patients with chronic congestive heart failure, NYHA class II–III; mean age 56 ± 12 years; sex not specified | 15 g | 5 days | 17 |
| Acute effect of amino acid ingestion and resistance exercise on plasma growth hormone concentration in young men 1997 · Trial B · young men | 1.5 g | 1 day | 16 |
| Acute effect of amino acid ingestion and resistance exercise on plasma growth hormone concentration in young men 1997 · Trial C · young men | 1.5 g | 1 day | 16 |
| Effects of arginine supplementation on the humoral and innate immune response of older people 2005 · arginine supplementation group · Adults aged 60 years and older living in the community | 15 g | 4 weeks | 15 |
| The effect of L-arginine and citrulline on endothelial function in patients in heart failure with preserved ejection fraction 2010 · L-arginine group · Adults with stable diastolic and right heart failure; age and sex not reported | 8 g | 60 days | 15 |
| Effect of L-arginine or L-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fraction 2010 · L-arginine group · Adults with chronic stable heart failure with preserved ejection fraction (HFpEF); age and sex not stated | 8 g | 60 days | 15 |
| L-arginine attenuates lymphocyte activation and anti-oxidized LDL antibody levels in patients undergoing angioplasty 2004 · L-arginine · Patients with unstable angina undergoing PCI with stent placement | 6 g | 30 days | 13 |
| Effects of arginine supplementation on post-exercise metabolic responses 2009 · arginine · Twelve healthy male judo athletes | 100 mg/kg | 1 day | 12 |
| Arginine supplementation is well tolerated but does not enhance mitogen-induced lymphocyte proliferation in elderly nursing home residents with pressure ulcers 2000 · 8.5 g arginine group · Elderly nursing-home residents with one or more pressure ulcers; mean age 81 years in this arm | 8.5 g | 4 weeks | 11 |
| Arginine supplementation is well tolerated but does not enhance mitogen-induced lymphocyte proliferation in elderly nursing home residents with pressure ulcers 2000 · 17 g arginine group · Elderly nursing-home residents with one or more pressure ulcers; mean age 87 years in this arm | 17 g | 4 weeks | 11 |
| Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women 2000 · L-arginine · Postmenopausal women receiving no estrogen | 9 g | 30 days | 10 |
| [Effect of L-arginine on platelet aggregation, endothelial function adn exercise tolerance in patients with stable angina pectoris] 2000 · L-arginine healthy control group · Healthy adult volunteers | 15 g | 10 days | 10 |
| Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study 2005 · L-arginine (crossover study) · Patients with cystic fibrosis; ages not reported; five females among 10 participants | 600 mg/kg | 6 weeks | 10 |
| Oral L-arginine modulates blood lactate and interleukin-6 after exercise in HIV-infected men 2014 · L-arg · HIV-infected men | 20 g | 1 day | 10 |
| l-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans 2015 · Arg · healthy adult men | 6 g | 7 days | 10 |
| Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study 2005 · L-arginine (pilot study, cystic fibrosis patients) · Patients with cystic fibrosis; ages and sex distribution not reported | 200 mg/kg | 1 day | 8 |
| Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study 2005 · L-arginine (pilot study, healthy controls) · Healthy controls; ages and sex distribution not reported | 200 mg/kg | 1 day | 8 |
| Oral arginine attenuates the growth hormone response to resistance exercise 2006 · arginine (Arg) · Eight healthy male subjects | 7 g | 1 day | 8 |
| Oral arginine attenuates the growth hormone response to resistance exercise 2006 · arginine + exercise (Arg+Ex) · Eight healthy male subjects | 7 g | 1 day | 8 |
| Short-term l-arginine supplementation attenuates elevation of interleukin 6 level after resistance exercise in overweight men 2017 · l-arg group · Eight obese hypertensive men, aged 46 ± 6 years | 6 g | 7 days | 8 |
| L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship 1998 · 6 g oral L-arginine · Healthy adult men | 6 g | 1 day | 8 |
| Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation 2000 · L-arg. group · People with severe chronic heart failure | 8 g | 4 weeks | — |
| Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation 2000 · L-arg. + T · People with severe chronic heart failure | 8 g | 4 weeks | — |
| Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study 2000 · L-arginine without atorvastatin · Young adults aged 18–46 with type I diabetes mellitus | 14 g | 6 weeks | — |
| Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study 2000 · L-arginine with atorvastatin · Young adults aged 18–46 with type I diabetes mellitus | 14 g | 6 weeks | — |
| Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients 2001 · Group 2, L-arginine period · Lean patients with type 2 diabetes; age and sex not reported | 9 g | 30 days | — |
| NO synthase inhibition increases aldosterone in humans 2004 · L-arginine · 10 normal human subjects | 9 g | — | — |
| NO synthase inhibition increases aldosterone in humans 2004 · L-arginine plus ramipril · 10 normal human subjects | 9 g | — | — |
| Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition 2006 · L-arginine · normal subjects | 9 g | 4 weeks | — |
| Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition 2006 · L-arginine+ramipril · normal subjects | 9 g | 4 weeks | — |
| Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass 2009 · L-arginine · Adults with cardiovascular disease who had previously undergone aortocoronary bypass and did not have diabetes | 6.4 g | 26 weeks | — |
| Acute l-arginine supplementation increases muscle blood volume but not strength performance 2012 · L-arginine (ARG) · 15 male participants; healthy subjects | 6 g | 1 day | — |
| Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial 2013 · L-arginine · Obese patients; age and sex not specified | 9 g | 26 weeks | — |
| Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity 2012 · L-arginine · Patients with visceral obesity; age and sex not specified | 9 g | 90 days | — |
| Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status 2012 · L-arginine 2 g tid · Adults with mild arterial hypertension; age range not reported; women and men | 6 g | 4 weeks | — |
| Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status 2012 · L-arginine 4 g tid · Adults with mild arterial hypertension; age range not reported; women and men | 12 g | 4 weeks | — |
| A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes 2013 · L-arginine · Children with sickle cell disease hospitalized for vaso-occlusive pain episodes | 300 mg/kg | 5 days | — |
| Arginine enhances wound healing and lymphocyte immune responses in humans 1990 · arginine hydrochloride group · healthy, nonsmoking human volunteers | 30 g | 2 weeks | — |
| Effect of L-arginine dietary supplementation on salivary urea concentration and pH in physically active individuals 2013 · L-arginine group · Physically active individuals | 3 g | 1 day | — |
| Consuming a mixed diet enriched with lupin protein beneficially affects plasma lipids in hypercholesterolemic subjects: a randomized controlled trial 2015 · milk protein plus arginine (MPA) · Adults with hypercholesterolemia | 1.6 g | 4 weeks | — |
| Effect of L-arginine supplementation on insulin resistance and adipocitokines levels in head and neck cancer non diabetic patients after surgery 2014 · Group I · Patients with head and neck cancer without type 2 diabetes, after surgery | 20 g | 10 days | — |
| Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir 2015 · Arginine group (PAOD study) · Patients with peripheral arterial occlusive disease; age and sex not stated | 10 g | 90 days | — |
| Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir 2015 · Arginine group (CAD study) · Patients with coronary artery disease; age and sex not stated | 10 g | 26 weeks | — |
| Combined effects of aerobic exercise and l-arginine ingestion on blood pressure in normotensive postmenopausal women: A crossover study 2016 · arginine (ARG) · Normotensive postmenopausal women; mean age 57±6 years | 9 g | 1 day | — |
| Intermittent Hypoxic Exposure with High Dose of Arginine Impact on Circulating Mediators of Tissue Regeneration 2020 · arginine group (Arg) · Elite male wrestlers on the national team, undergoing preparatory training; adults, exact ages not reported. | 12 g | 12 days | — |
| Intermittent Hypoxic Exposure with High Dose of Arginine Impact on Circulating Mediators of Tissue Regeneration 2020 · arginine with hypoxic exposure group (Arg/IHE) · Elite male wrestlers on the national team, undergoing preparatory training; adults, exact ages not reported. | 12 g | 12 days | — |
| A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients 2022 · AES · Colorectal cancer surgery patients; age range and sex not reported | 12.6 g | 10 days | — |
| Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia 2025 · L-arginine study group · Men and women over 50 years of age with Fontaine stage II atherosclerotic lower limb ischemia | 6 g | 60 days | — |
| Dietary supplementation with L-arginine: modulation of tumour-infiltrating lymphocytes in patients with colorectal cancer 1997 · standard diet supplemented with L-arginine · Patients with colorectal cancer | 30 g | 3 days | — |
| Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine 1997 · arginine HCl · hypercholesterolemic subjects | 8.4 g | 2 weeks | — |
| Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial 2023 · l-arginine plus vitamin C · Men and women aged 20–60 with long COVID and persistent fatigue after confirmed SARS-CoV-2 infection | 3.32 g | 4 weeks | 23 |
| Perioperative immunonutrition in well-nourished patients undergoing surgery for head and neck cancer: evaluation of inflammatory and immunologic outcomes 2013 · Immunonutrition (IMN) group · Patients aged 17 years and older with normal nutritional status undergoing radical resection for oral cavity, pharyngeal or laryngeal cancer | 11.3 g | 11 days | 4 |
| Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial 2015 · L-arginine · Individuals with impaired glucose tolerance and metabolic syndrome | 6.4 g | 548 days | — |
| The effects of preoperative supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine on inflammatory and hematological markers of patients with heart surgery: a randomized controlled trial 2022 · Heallagen® group · Adults aged 18–70 undergoing cardiac surgery | 7 g | 30 days | 30 |
| Evaluation of the recovery after heart surgery following preoperative supplementation with a combination of beta-hydroxy-beta-methylbutyrate, L-arginine, and L-glutamine: a double-blind randomized placebo-controlled clinical trial 2022 · Gln/Arg/HMB · Adults aged 18–70 undergoing cardiac surgery | 14 g | 30 days | 30 |
| Arginine stimulates wound healing and immune function in elderly human beings 1993 · arginine-supplemented group · Healthy adults older than 65 years, men and women | 17 g | 2 weeks | 30 |
| Metabolic effects of arginine in a healthy elderly population 1995 · arginine aspartate · Healthy, nonsmoking elderly volunteers; age range and sex not reported | 17 g | 2 weeks | 30 |
| Effect of a specialized amino acid mixture on human collagen deposition 2002 · Specialized amino acid mixture · Healthy, nonsmoking adults aged 70 years or older | 14 g | 2 weeks | 18 |
| Acute supplementation with an amino acid mixture suppressed the exercise-induced cortisol response in recreationally active healthy volunteers: a randomized, double-blinded, placebo-controlled crossover study 2020 · AA condition · Healthy recreationally active men aged 20–39 years | 1.8 g | 1 day | 15 |
| Effects of L-arginine supplementation on endothelial function after stent implantation 2002 · L-arginine · Patients undergoing coronary stent implantation after percutaneous coronary intervention | 6 g | 2 weeks | — |
| Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety 2005 · L-lysine and L-arginine mixture · Healthy subjects at the upper limit of the normal range of a trait anxiety scale | 3 g | 10 days | — |
| High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial 2009 · group I · Patients with oral or laryngeal cancer undergoing surgery | 20 g | — | — |
| Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial 2012 · L-arginine, selenium and HDEL · Premenopausal women with central obesity | 5 g | 6 weeks | — |
| Impact of preoperative beta-hydroxy-beta-methylbutyrate, arginine, and glutamine supplementation on inflammation in patients with cardiac surgery: A secondary analysis of a randomized controlled trial 2025 · HMB supplementation · Patients aged 65 years or older scheduled for elective cardiac surgery | 14 g | 2 weeks | — |
| The effects of an amino acid supplement on glucose homeostasis, inflammatory markers, and incretins after laparoscopic gastric bypass 2011 · experimental group · Adults with morbid obesity undergoing laparoscopic gastric bypass; age and sex range not reported | 14 g | 8 weeks | 14 |
| Multinutrient Supplementation Increases Collagen Synthesis during Early Wound Repair in a Randomized Controlled Trial in Patients with Inguinal Hernia 2020 · multinutrient group · Men scheduled for Lichtenstein inguinal hernia repair; mean age 55.2 years, with inguinal hernia disease | 14 g | 4 weeks | 10 |
| Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial 2008 · L-arginine plus placebo injection · Patients with surgical triple-vessel coronary disease and a severely diffusely diseased left anterior descending artery | 6 g | 90 days | — |